Along with the positive immunofluorescence for cancer stem cell biomarkers (OCT4, NANOG, and SOX-2), these findings indicated the involvement of primitive embryonic cells as the origin of MCMT and concluded that MCMT may not come from colliding tumors, but from a single stem cell. The gene discussed is SOX2; the disease is cancer.